Gentolex’s story can be traced back to the summer of 2013, a group of young people with a vision in the industry to create opportunities connecting the world with better services and products guarantee.
major
products
Chemicals Products
Chemicals Products
An overall factory construction area of 250,000 square meters under international standard to offer flexible, scalable and cost-effective solutions.
Pharmaceutical Ingredients
Pharmaceutical Ingredients
Gentolex offers an extensive range of APIs and intermediates for development study and commercial application with cGMP standard from long-term collaborations. Documents and Certificates are supported to customers worldwide.
CRO&CDMO
CRO&CDMO
We have rich experience of offering CRO and CDMO services throughout the peptide drug development process for IND, NDA & ANDA projects, provide safe and efficient guidance from development to commercial production.
Procurement Service
Procurement Service
For those clients who prefer to avoid the complexity of dealing with multiple points of contact, we provide extra customized procurement services with the most superior and comprehensive supply chain sources.
about
Gentolex
Gentolex’s story can be traced back to the summer of 2013, a group of young people with a vision in the industry to create opportunities connecting the world with better services and products guarantee. Up to date, with years of accumulation, Gentolex Group has been serving customers from more than 15 countries across 5 continents, specially, representative teams are established in Mexico and South Africa, soon, more representative teams will be established for business services.
news and information
The sales comparision of Dulaglutide, Liraglutide and Semaglutide.
Pharmaceutical giant Lilly, an American company, and Novo Nordisk, a Danish company, have successively announced the sales data of their main products in 2020: Dulaglutide has become a TOP1 GLP-1 drug, with sales of $5.07Bn in 2020, a year-on-year increase of 22.8%; liraglutide Beginning to enter...
Does growth hormone slow or accelerate aging?
GH/IGF-1 decreases physiologically with age, and these changes are accompanied by fatigue, muscle atrophy, increased adipose tissue, and cognitive deterioration in the elderly… In 1990, Rudman published a paper in the New England Journal of Medicine that shocked the medical community –...
New Products Alert
In order to provide more options to the clients in Cosmetic peptides industry, Gentolex will constantly add new products to the list. High quality with varieties categories, there are totally four different series defined by functions in protecting skins, including Anti-aging & anti-wrinkle, ...
Acadia Trofinetide Phase III Clinical Top-Line Results Positive
On 2021-12-06, US time, Acadia Pharmaceuticals (Nasdaq: ACAD) announced the positive top-line results of its Phase III clinical trial of its drug candidate, Trofinetide. The phase III trial, called Lavender, is mainly used to evaluate the safety and efficacy of Trofinetide in the treatment of Ret...
The research progress of opioid peptides from the approval of Difelikefalin
As early as 2021-08-24, Cara Therapeutics and its business partner Vifor Pharma announced that its first-in-class kappa opioid receptor agonist difelikefalin (KORSUVA™) was approved by the FDA for the treatment of chronic kidney disease (CKD) patients (positive Moderate/severe pruritus with hemod...